Annexon Inc.
Organization details
- Legal name
- Annexon Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Brisbane
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ANNX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001528115
- EIN
- 27-5414423
Board of directors
-
Bettina M. Cockroft · DirectorSince 2023
-
Douglas Love · Director · PRESIDENT AND CEOSince 2023
-
Jung Choi · DirectorSince 2023
-
Mark S. Blumenkranz · DirectorSince 2026
-
Muneer A. Satter · DirectorSince 2023
-
Thomas G. Wiggans · DirectorSince 2023
-
William A. Jones Jr. · DirectorSince 2025
-
William D. Waddill · DirectorSince 2023
-
William H. Carson · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 11, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
81.7%
-
86.4%
Board connections
5 of this board's directors also sit on 7 other boards. 7 are in the same sector.
-
Apnimed Inc. Same sectorvia William A. Jones Jr.
-
Arrowhead Pharmaceuticals Inc. Same sectorvia William D. Waddill
-
CNS Pharmaceuticals Inc. Same sectorvia Bettina M. Cockroft
-
Jasper Therapeutics Inc. Same sectorvia Thomas G. Wiggans
-
KALA BIO Inc. Same sectorvia Mark S. Blumenkranz
-
Pacira BioSciences Inc. Same sectorvia Thomas G. Wiggans
-
Protagonist Therapeutics Inc. Same sectorvia William D. Waddill
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $12,393,153
- 13 purchases by 4 insiders
- Sold, last 12 months
- $313,428
- 10 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 24, 2026 | Douglas Love Director, Officer (PRESIDENT AND CEO) | Open-market purchase | +26,065 | $3.83 | $99,829 |
| Jun 11, 2026 | Yednock Ted Officer (EVP & CHIEF INNOVATION OFFICER) | Option exercise | +30,646 | $1.85 | $56,695 |
| May 28, 2026 | Muneer A. Satter Director | Open-market purchase | +613,497 | $5.41 | $3,319,019 |
| May 11, 2026 | William H. Carson Director | Open-market purchase | +8,000 | $5.78 | $46,240 |
| Apr 10, 2026 | William H. Carson Director | Open-market purchase | +8,000 | $6.20 | $49,600 |
| Mar 10, 2026 | William H. Carson Director | Open-market purchase | +8,000 | $5.67 | $45,360 |
| Mar 2, 2026 | Dananberg Jamie Officer (CHIEF MEDICAL OFFICER) | Open-market sale | −5,820 | $5.43 | $31,603 |
| Mar 2, 2026 | Overdorf Michael Officer (EVP & CHIEF BUSINESS OFFICER) | Open-market sale | −4,339 | $5.42 | $23,517 |
| Mar 2, 2026 | Yednock Ted Officer (EVP & CHIEF INNOVATION OFFICER) | Open-market sale | −5,566 | $5.42 | $30,168 |
| Mar 2, 2026 | ARTIS DEAN RICHARD Officer (EVP & CHIEF SCIENTIFIC OFFICER) | Open-market sale | −5,894 | $5.43 | $32,004 |
| Mar 2, 2026 | Jennifer Lew Officer (EVP & CHIEF FINANCIAL OFFICER) | Open-market sale | −5,565 | $5.42 | $30,162 |
| Feb 19, 2026 | Dananberg Jamie Officer (CHIEF MEDICAL OFFICER) | Grant or award | +56,250 | — | — |
| Feb 19, 2026 | Overdorf Michael Officer (EVP & CHIEF BUSINESS OFFICER) | Grant or award | +62,500 | — | — |
| Feb 19, 2026 | ARTIS DEAN RICHARD Officer (EVP & CHIEF SCIENTIFIC OFFICER) | Grant or award | +62,500 | — | — |
| Feb 19, 2026 | Yednock Ted Officer (EVP & CHIEF INNOVATION OFFICER) | Grant or award | +62,500 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Annexon Inc.
Who is the CEO of Annexon Inc.?
Douglas Love is Annexon Inc.'s President & CEO.
How many directors are on Annexon Inc.'s board?
Annexon Inc.'s board has 9 directors: Bettina M. Cockroft, Douglas Love, Jung Choi, Mark S. Blumenkranz, Muneer A. Satter, Thomas G. Wiggans, William A. Jones Jr., William D. Waddill and William H. Carson.
Are Annexon Inc. insiders buying or selling shares?
Over the last 12 months, Annexon Inc. insiders bought $12.4 million of shares in 13 purchases and sold $313,428 of shares in 10 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="annexon-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.